Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults.
Journal: Antimicrobial agents and chemotherapy
Published: April 20, 2026
Pharmacokinetics and safety of single and repeat doses of ceftibuten in healthy participants: a phase 1 dose escalation study.
Journal: Antimicrobial agents and chemotherapy
Published: August 05, 2025
Safety and pharmacokinetics of single and multiple doses of ledaborbactam etzadroxil with or without ceftibuten in healthy volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: August 05, 2025
Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants.
Journal: Antimicrobial agents and chemotherapy
Published: June 06, 2025
Cefepime-Taniborbactam in Complicated Urinary Tract Infection. Reply.
Journal: The New England journal of medicine
Published: May 29, 2024
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection.
Journal: Antimicrobial agents and chemotherapy
Published: May 23, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
Journal: The New England journal of medicine
Published: February 14, 2024
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics.
Journal: Antimicrobial agents and chemotherapy
Published: March 14, 2023
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia.
Journal: Antimicrobial agents and chemotherapy
Published: December 19, 2022
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs.
Journal: Infectious diseases and therapy
Published: November 16, 2021
Safety and efficacy of omadacycline by body mass index in patients with community-acquired bacterial pneumonia: Subanalysis from a randomized controlled trial.
Journal: Respiratory medicine
Published: January 15, 2021
Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.
Journal: Open forum infectious diseases
Published: November 19, 2020
Last Updated: 09/26/2026